Post-approval Study of NovoTTF-100A in Recurrent GBM Patients

NCT01756729 · clinicaltrials.gov ↗

PHASE4

Phase

TERMINATED

Status

13

Enrollment

INDUSTRY

Sponsor class

Stopped Amendment of Study Protocol

Conditions

Recurrent Glioblastoma Multiforme

Interventions

DEVICE: NovoTTF-100A

Sponsor

NovoCure Ltd.